chr19-4352994-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001300862.2(MPND):c.629C>A(p.Pro210Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000117 in 1,364,040 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001300862.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPND | NM_001300862.2 | c.629C>A | p.Pro210Gln | missense_variant | 4/13 | ENST00000599840.6 | NP_001287791.1 | |
MPND | NM_032868.6 | c.629C>A | p.Pro210Gln | missense_variant | 4/12 | NP_116257.2 | ||
MPND | NM_001159846.3 | c.629C>A | p.Pro210Gln | missense_variant | 4/11 | NP_001153318.1 | ||
MPND | XM_006722926.3 | c.629C>A | p.Pro210Gln | missense_variant | 4/13 | XP_006722989.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPND | ENST00000599840.6 | c.629C>A | p.Pro210Gln | missense_variant | 4/13 | 5 | NM_001300862.2 | ENSP00000471735 | P2 | |
ENST00000594776.1 | n.246+818G>T | intron_variant, non_coding_transcript_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152090Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000779 AC: 1AN: 128358Hom.: 0 AF XY: 0.0000144 AC XY: 1AN XY: 69428
GnomAD4 exome AF: 0.00000908 AC: 11AN: 1211832Hom.: 0 Cov.: 33 AF XY: 0.00000170 AC XY: 1AN XY: 589208
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74408
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 03, 2022 | The c.629C>A (p.P210Q) alteration is located in exon 4 (coding exon 4) of the MPND gene. This alteration results from a C to A substitution at nucleotide position 629, causing the proline (P) at amino acid position 210 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at